UK markets open in 7 hours 59 minutes
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,578.30 +102.38 (+0.55%) CRUDE OIL
78.75 +0.27 (+0.34%) GOLD FUTURES
2,334.90 +3.70 (+0.16%) DOW
38,852.27 +176.59 (+0.46%) Bitcoin GBP
50,541.44 -302.45 (-0.59%)
Keros Therapeutics, Inc. (KROS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.18B |
| Enterprise value | 1.87B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 11.81k |
| Price/book (mrq) | 6.58 |
| Enterprise value/revenue | 12.37k |
| Enterprise value/EBITDA | -12.27 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.27 |
| 52-week change 3 | 32.48% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 73.00 |
| 52-week low 3 | 27.02 |
| 50-day moving average 3 | 63.25 |
| 200-day moving average 3 | 44.66 |
Share statistics
| Avg vol (3-month) 3 | 352.19k |
| Avg vol (10-day) 3 | 319.48k |
| Shares outstanding 5 | 36.07M |
| Implied shares outstanding 6 | 36.07M |
| Float 8 | 30.85M |
| % held by insiders 1 | 6.36% |
| % held by institutions 1 | 88.35% |
| Shares short (15 Apr 2024) 4 | 2.26M |
| Short ratio (15 Apr 2024) 4 | 6.49 |
| Short % of float (15 Apr 2024) 4 | 8.92% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.26% |
| Shares short (prior month 15 Mar 2024) 4 | 1.92M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -32,486.01% |
Management effectiveness
| Return on assets (ttm) | -31.39% |
| Return on equity (ttm) | -50.19% |
Income statement
| Revenue (ttm) | 151k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -169.13M |
| Net income avi to common (ttm) | -152.99M |
| Diluted EPS (ttm) | -5.20 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 331.15M |
| Total cash per share (mrq) | 9.2 |
| Total debt (mrq) | 14.44M |
| Total debt/equity (mrq) | 4.35% |
| Current ratio (mrq) | 14.25 |
| Book value per share (mrq) | 10.43 |
Cash flow statement
| Operating cash flow (ttm) | -124.51M |
| Levered free cash flow (ttm) | -81.25M |
© 2024 Yahoo. All rights reserved.